Tolerability of paracetamol.

Area of Science:

• Pharmacology
• Hepatology
• Gastroenterology

Background:

• Paracetamol (acetaminophen) is widely used due to its excellent tolerability at therapeutic doses.
• Overdose is the main cause of paracetamol-induced hepatotoxicity.
• Concerns exist regarding toxicity at therapeutic doses and interactions with alcohol, gastrointestinal issues, and chronic diseases.

Purpose of the Study:

• To critically evaluate the safety profile of paracetamol (acetaminophen) at therapeutic doses.
• To assess the risk of hepatotoxicity, gastrointestinal toxicity, and other adverse effects.
• To clarify the association between paracetamol use and specific patient populations, including pregnant women and alcohol consumers.

Main Methods:

• Critical analysis of existing literature, including prospective studies and controlled clinical trials.
• Review of case-control studies investigating gastrointestinal toxicity, chronic renal disease, and asthma.
• Evaluation of data on hypersensitivity reactions and use during pregnancy.

Main Results:

• Therapeutic doses of paracetamol are unlikely to cause hepatotoxicity, even with moderate to heavy alcohol intake.
• Paracetamol is well-tolerated by the gastrointestinal tract; associations with GI toxicity may be due to study biases.
• Apparent links to chronic renal disease and asthma are likely biased due to paracetamol's perceived safety.
• Hypersensitivity reactions are rare; safety in pregnancy requires further prospective studies.

Conclusions:

• Paracetamol (acetaminophen) demonstrates excellent tolerability at therapeutic doses, with overdose being the primary risk factor for hepatotoxicity.
• The drug is safe for the gastrointestinal tract, and associations with other conditions are likely due to confounding factors.
• Further research is needed to confirm safety during pregnancy.